ICCM
IceCure Medical·NASDAQ
--
--(--)
--
--(--)
5.66 / 10
Netural
Fund flow data reveal a good score of 7.31, yet all flow trends (overall, block, small, medium, large, extra-large) are negative, hinting at underlying selling pressure. Analyst coverage is minimal with only one active analyst issuing a Strong Buy rating; historical win rate is 50%, and the current price trend is falling (-10.13%), underscoring a mismatch between optimistic expectations and market reality.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-07
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate50.0%
What is the market sentiment for ICCM?
- ICCM holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.66/10 (Netural).
